Hypermarcas (OTCMKTS:HYPMY) Sees Strong Trading Volume – Still a Buy?

Hypermarcas (OTCMKTS:HYPMY) saw unusually-high trading volume on Friday . Approximately 118,047 shares traded hands during trading, an increase of 361% from the previous session’s volume of 25,629 shares.The stock last traded at $4.12 and had previously closed at $4.04.

Analyst Ratings Changes

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a research note on Wednesday, April 29th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Buy”.

Hypermarcas Stock Up 2.0%

The company has a fifty day moving average of $4.51 and a two-hundred day moving average of $4.47. The company has a market cap of $2.90 billion, a PE ratio of 8.58 and a beta of 0.70. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.84 and a current ratio of 1.27.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.10 earnings per share for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The company had revenue of $383.13 million for the quarter. As a group, analysts anticipate that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.